The investment firm attributed its target cut to weak volumes, production issues, and soft demand in autos and tow markets.

RBC Capital raised its price target on Celestica Inc. (NYSE:CLS) from $185 to $225 on July 30, 2025, maintaining an ...

The price of gold isn't dictated by macro variables alone. In fact, the RBC strategy team thinks that when assessing gold on pure fundamentals it's probably overvalued. But if things play out a ...

The recent outperformance in small-cap stocks will probably run out of steam after rallying on increased optimism that the Federal Reserve will lower interest rates over the next year, according to ...

BHP's shift in focus from iron ore to copper helped the company report a stronger than expected profit for the 2025 financial ...

Supporters argue RBC ratios have limited use and ranking insurers by them is inappropriate. On the other hand, critics, ...

It's been a rough past few days for Snap (NYSE: SNAP) shareholders. The Snapchat parent's stock is trading down more than 20% ...

The National Insurance Commission (NAICOM) has issued fresh directives for the implementation of the new Minimum Capital Requirement (MCR) for insurers and reinsurers in Nigeria, making clear that ...

State insurance regulators are moving with alacrity on a plan to overhaul the risk-based capital (RBC) framework by the end of 2025.

A proposal to make a key measure of insurance companies’ financial health confidential is teed up for regulators to tackle in October.

J.P. Morgan, BofA Securities and RBC Capital Markets are acting as joint lead book-running managers for the offering. BMO Capital Markets, KeyBanc Capital Markets, Morgan Stanley and Wells Fargo ...

Sarepta Therapeutics said Friday that the deaths of two patients taking its marketed gene therapy Elevidys® (delandistrogene ...